Search

Your search keyword '"Braam, Pètra"' showing total 171 results
Start Over Author "Braam, Pètra"
171 results on '"Braam, Pètra"'

1. Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort

Author

Alongi, Filippo, Nicosia, Luca, Ricardi, Umberto, Scorsetti, Marta, Greto, Daniela, Balermpas, Panagiotis, Lievens, Yolande, Braam, Pètra, Jereczek-Fossa, Barbara Alicja, Stellamans, Karin, Ratosa, Ivica, Simek, Inga-Malin, Peulen, Heike, Dirix, Piet, Verbeke, Luc, Ramella, Sara, Hemmatazad, Hossein, Khanfir, Kaouthar, Geets, Xavier, Jeene, Paul, Zilli, Thomas, Fournier, Beatrice, Fortpied, Catherine, Boakye Oppong, Felix, Ost, Piet, and Guckenberger, Matthias

Published
2024
Full Text
View/download PDF

2. Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study

Author

Christ, Sebastian M., Alongi, Filippo, Ricardi, Umberto, Scorsetti, Marta, Livi, Lorenzo, Balermpas, Panagiotis, Lievens, Yolande, Braam, Pètra, Jereczek-Fossa, Barbara Alicja, Stellamans, Karin, Ratosa, Ivica, Widder, Joachim, Peulen, Heike, Dirix, Piet, Bral, Samuel, Ramella, Sara, Hemmatazad, Hossein, Khanfir, Kaouthar, Geets, Xavier, Jeene, Paul, Zilli, Thomas, Fournier, Beatrice, Ivaldi, Giovanni Battista, Clementel, Enrico, Fortpied, Catherine, Oppong, Felix Boakye, Ost, Piet, and Guckenberger, Matthias

Published
2024
Full Text
View/download PDF

4. Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort

Author

Bultijnck, Renée, Van Hemelrijck, Mieke, Fonteyne, Valérie, Livi, Lorenzo, Jereczek-Fossa, Barbara Alicja, Hemmatazad, Hossein, Mayinger, Michael, Peulen, Heike, Verbeke, Luc, Ramella, Sara, Castro, Pablo, Tsoutsou, Pelagia, Stellamans, Karin, Shaukat, Adnan, Orazem, Miha, Jeene, Paul, Braam, Pètra, Verkooijen, Helena, Simek, Inga-Malin, Alongi, Filippo, Clementel, Enrico, Fortpied, Catherine, Machingura, Abigirl, Boakye Oppong, Felix, Guckenberger, Matthias, and Ost, Piet

Published
2024
Full Text
View/download PDF

5. Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022

Author

Andreou, Dimosthenis, Barth, Thomas, Bauer, Sebastian, Blay, Jean-Yves, Blum, Veronika, Bode, Beata, Bonvalot, Sylvie, Bovee, Judith, Braam, Petra, Brodowicz, Thomas, Broto, Jean Martin, Dei Tos, Angelo, Denschlag, Dominik, Desar, Ingrid, Digklia, Antonia, Dileo, Palma, Dirksen, Uta, Douchy, Thomas, Duffaud, Florence, Eriksson, Mikael, Fröhling, Stefan, Gelderblom, Hans, Gronchi, Alessandro, Haas, Rick, Hardes, Jenrik, Hartmann, Wolfgang, Hofer, Silvia, Hohenberger, Peter, Hompes, Daphne, Huang, Paul, Italiano, Antoine, Jakob, Jens, Jones, Robin, Judson, Ian, Köhler, Günter, Kollàr, Attila, Krasniqi, Fatime, Krol, Stijn, Kunz, Wolfgang, Le Grange, Franel, Le Pechoux, Cécile, LeCesne, Alexandre, Leithner, Andreas, Liegl-Atzwanger, Bernadette, Lindner, Lars, Mechtersheimer, Gunhild, Messiou, Christina, Miah, Aisha, Pink, Daniel, Reichardt, Peter, Romagosa, Cleo, Rothermundt, Christian, Rutkowski, Piotr, Safwat, Akmel, Sangalli, Claudia, Szkandera, Joanna, Thway, Khin, Tunn, Per-Ulf, Van der Graaf, Winette, Van Houdt, Winan, Wardelmann, Eva, Zachariah, Ralph, Botter, Sander, Cerny, Thomas, Desar, Ingrid M.E., Jones, Robin L., Kunz, Wolfgang G., Liegl-Atzwanger, Berndadette, Lindner, Lars H., Miah, Aisha B., van der Graaf, Winette T.A., and van Houdt, Winan J.

Published
2023
Full Text
View/download PDF

9. The Dutch–Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases

Author

Méndez Romero, Alejandra, Schillemans, Wilco, van Os, Rob, Koppe, Friederike, Haasbeek, Cornelis J., Hendriksen, Ellen M., Muller, Karin, Ceha, Heleen M., Braam, Pètra M., Reerink, Onne, Intven, Martijn P.M., Joye, Ines, Jansen, Edwin P.M., Westerveld, Henrike, Koedijk, Merel S., Heijmen, Ben J.M., and Buijsen, Jeroen

Published
2021
Full Text
View/download PDF

10. Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort

Author

Trialbureau Beeld, Cancer, Bultijnck, Renée, Van Hemelrijck, Mieke, Fonteyne, Valérie, Livi, Lorenzo, Jereczek-Fossa, Barbara Alicja, Hemmatazad, Hossein, Mayinger, Michael, Peulen, Heike, Verbeke, Luc, Ramella, Sara, Castro, Pablo, Tsoutsou, Pelagia, Stellamans, Karin, Shaukat, Adnan, Orazem, Miha, Jeene, Paul, Braam, Pètra, Verkooijen, Helena, Simek, Inga Malin, Alongi, Filippo, Clementel, Enrico, Fortpied, Catherine, Machingura, Abigirl, Boakye Oppong, Felix, Guckenberger, Matthias, Ost, Piet, Trialbureau Beeld, Cancer, Bultijnck, Renée, Van Hemelrijck, Mieke, Fonteyne, Valérie, Livi, Lorenzo, Jereczek-Fossa, Barbara Alicja, Hemmatazad, Hossein, Mayinger, Michael, Peulen, Heike, Verbeke, Luc, Ramella, Sara, Castro, Pablo, Tsoutsou, Pelagia, Stellamans, Karin, Shaukat, Adnan, Orazem, Miha, Jeene, Paul, Braam, Pètra, Verkooijen, Helena, Simek, Inga Malin, Alongi, Filippo, Clementel, Enrico, Fortpied, Catherine, Machingura, Abigirl, Boakye Oppong, Felix, Guckenberger, Matthias, and Ost, Piet

Published
2024

11. Interobserver variation in tumor delineation of liver metastases using Magnetic Resonance Imaging

Author

MS Radiotherapie, Cancer, Peltenburg, Julia E., Hosni, Ali, Bahij, Rana, Boeke, Simon, Braam, Pètra M., Hall, William A., Intven, Martijn P.W., Nicosia, Luca, Sonke, Jan Jakob, Witte, Marnix, Nowee, Marlies E., Janssen, Tomas, MS Radiotherapie, Cancer, Peltenburg, Julia E., Hosni, Ali, Bahij, Rana, Boeke, Simon, Braam, Pètra M., Hall, William A., Intven, Martijn P.W., Nicosia, Luca, Sonke, Jan Jakob, Witte, Marnix, Nowee, Marlies E., and Janssen, Tomas

Published
2024

14. International real-world study of TOTAL neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC).

Author

Audisio, Alessandro, primary, Velenik, Vaneja, additional, Meillat, Hélène, additional, Ruiz-Garcia, Erika, additional, Riesco Martinez, Maria Carmen, additional, Dekervel, Jeroen, additional, Carvalho, Carlos Torres, additional, Suárez, Francisco Javier, additional, Kirac, Iva, additional, Hernando, Jorge, additional, Artac, Mehmet, additional, O'Connor, Juan Manuel, additional, Braam, Pètra, additional, Shamseddine, Ali, additional, Borelli, Beatrice, additional, Paez Lopez-Bravo, David, additional, Dulskas, Audrius, additional, De Felice, Francesca, additional, Vanden Bulcke, Alexander, additional, and Sclafani, Francesco, additional

Published
2024
Full Text
View/download PDF

15. Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial)

Author

Méndez Romero, Alejandra, primary, van der Holt, Bronno, additional, Willemssen, Francois E.J.A., additional, de Man, Rob A., additional, Heijmen, Ben J.M., additional, Habraken, Steven, additional, Westerveld, Henrike, additional, van Delden, Otto M., additional, Klümpen, Heinz-Josef, additional, Tjwa, Eric T.T.L., additional, Braam, Pètra M., additional, Jenniskens, Sjoerd F.M., additional, Vanwolleghem, Thomas, additional, Weytjens, Reinhilde, additional, d'Archambeau, Olivier, additional, de Vos-Geelen, Judith, additional, Buijsen, Jeroen, additional, van der Leij, Christiaan, additional, den Toom, Wilhelm, additional, Sprengers, Dave, additional, IJzermans, Jan N.M., additional, and Moelker, Adriaan, additional

Published
2023
Full Text
View/download PDF

16. The TRENDY multi-center randomized trial on hepatocellular carcinoma – Trial QA including automated treatment planning and benchmark-case results

Author

Habraken, Steven J.M., Sharfo, Abdul Wahab M., Buijsen, Jeroen, Verbakel, Wilko F.A.R., Haasbeek, Cornelis J.A., Öllers, Michel C., Westerveld, Henrike, van Wieringen, Niek, Reerink, Onne, Seravalli, Enrica, Braam, Pètra M., Wendling, Markus, Lacornerie, Thomas, Mirabel, Xavier, Weytjens, Reinhilde, Depuydt, Lieselotte, Tanadini-Lang, Stephanie, Riesterer, Oliver, Haustermans, Karin, Depuydt, Tom, Dwarkasing, Roy S., Willemssen, François E.J.A., Heijmen, Ben J.M., and Méndez Romero, Alejandra

Published
2017
Full Text
View/download PDF

18. 1935: Early Quality-of-Life after metastases-directed SBRT– results of the ESTRO & EORTC OligoCare cohort

Author

Greto, Daniela, van Hemelrijck, Mieke, Oppong, Felix, Lievens, Yolande, Ratosa, Ivica, Jereczek-Fossa, Barbara Alicja, Stellamans, Karin, Peulen, Heike, Verbeke, Luc, hemmatazad, Hossein, Ramella, Sara, Braam, Pètra, Ivaldi, Giovanni Battista, Zapatero, Almudena, Adnan, Shaukat, Tsoutsou, Pelagia, Cruz, Olalla Santa, Sancho-Pardo, Gemma, Ost, Piet, and Guckenberger, Matthias

Published
2024
Full Text
View/download PDF

22. Myxoid liposarcoma of the foot: a study of 8 cases

Author

Bekers, Elise M., Song, Wangzhao, Suurmeijer, Albert J.H., Bonenkamp, Johannes J., van der Geest, Ingrid C., Braam, Petra M., Ploegmakers, Marieke J.M., Desar, Ingrid M.E., Tops, Bastiaan B.J., van Gorp, Joost M., Creytens, David H., Mentzel, Thomas, and Flucke, Uta

Published
2016
Full Text
View/download PDF

23. The Prognostic Relevance of MRI Characteristics in Myxofibrosarcoma Patients Treated with Neoadjuvant Radiotherapy

Author

van Ravensteijn, Stefan G., primary, Nederkoorn, Maikel J. L., additional, Wal, Tom C. P., additional, Versleijen-Jonkers, Yvonne M. H., additional, Braam, Pètra M., additional, Flucke, Uta E., additional, Bonenkamp, Johannes J., additional, Schreuder, Bart H. W., additional, van Herpen, Carla M. L., additional, de Wilt, Johannes H. W., additional, Desar, Ingrid M. E., additional, and de Rooy, Jacky W. J., additional

Published
2023
Full Text
View/download PDF

24. Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma:Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial)

Author

Méndez Romero, Alejandra, van der Holt, Bronno, Willemssen, Francois E.J.A., de Man, Rob A., Heijmen, Ben J.M., Habraken, Steven, Westerveld, Henrike, van Delden, Otto M., Klümpen, Heinz Josef, Tjwa, Eric T.T.L., Braam, Pètra M., Jenniskens, Sjoerd F.M., Vanwolleghem, Thomas, Weytjens, Reinhilde, d'Archambeau, Olivier, de Vos-Geelen, Judith, Buijsen, Jeroen, van der Leij, Christiaan, den Toom, Wilhelm, Sprengers, Dave, IJzermans, Jan N.M., Moelker, Adriaan, Méndez Romero, Alejandra, van der Holt, Bronno, Willemssen, Francois E.J.A., de Man, Rob A., Heijmen, Ben J.M., Habraken, Steven, Westerveld, Henrike, van Delden, Otto M., Klümpen, Heinz Josef, Tjwa, Eric T.T.L., Braam, Pètra M., Jenniskens, Sjoerd F.M., Vanwolleghem, Thomas, Weytjens, Reinhilde, d'Archambeau, Olivier, de Vos-Geelen, Judith, Buijsen, Jeroen, van der Leij, Christiaan, den Toom, Wilhelm, Sprengers, Dave, IJzermans, Jan N.M., and Moelker, Adriaan

Abstract

Purpose: To compare transarterial chemoembolization delivered with drug eluting beads (TACE-DEB) with stereotactioc body radiation therapy (SBRT) in patients with hepatocellular carcinoma (HCC) in a multicenter randomized trial. Methods and Materials: Patients were included if they were eligible for TACE. They could also be recruited if they required treatment prior to liver transplantation. A maximum of four TACE-DEB procedures and ablation after incomplete TACE-DEB were both allowed. SBRT was delivered in six fractions of 8-9Gy. Primary end point was time to progression (TTP). Secondary endpoints were local control (LC), overall survival (OS), response rate (RR), toxicity, and quality of life (QoL). The calculated sample size was 100 patients. Results: Between May 2015 and April 2020, 30 patients were randomized to the study. Due to slow accrual the trial was closed prematurely. Two patients in the SBRT arm were considered ineligible leaving 16 patients in the TACE-DEB arm and 12 in the SBRT arm. Median follow-up was 28.1 months. Median TTP was 12 months for TACEDEB and 19 months for SBRT (p=0.15). Median LC was 12 months for TACE-DEB and >40 months (not reached) for SBRT (p=0.075). Median OS was 36.8 months for TACEDEB and 44.1 months for SBRT (p=0.36). A post-hoc analysis showed 100% for SBRT 1- and 2-year LC, and 54.4% and 43.6% for TACE-DEB (p=0.019). Both treatments resulted in RR>80%. Three episodes of possibly related toxicity grade ≥3 were observed after TACE-DEB. No episodes were observed after SBRT. QoL remained stable after both treatment arms. Conclusions: In this trial, TTP after TACE-DEB was not significantly improved by SBRT, while SBRT showed higher local antitumoral activity than TACE-DEB, without detrimental effects on OS, toxicity and QoL. To overcome poor accrual in randomized trials that include SBRT, and to generate evidence for including SBRT in treatment guidelines, international cooperation is needed.

Published
2023

25. Small Cell Carcinoma of the Esophagus: A Nationwide Analysis of Treatment and Outcome at Patient Level in Locoregional Disease

Author

Jeene, Paul M., Geijsen, Elisabeth D., Muijs, Christina T., Rozema, Tom, Aleman, Berthe M.P., Muller, Karin, Baas, Jara M., Nuyttens, Joost J., Wouterse, Sanne, Braam, Pètra M., Oppedijk, Vera, Ceha, Heleen M., Cnossen, Jeltsje, Spruit, Patty, Bongers, Eva M., Berbée, Maaike, Mook, Stella, and Hulshof, Maarten C.C.M.

Published
2019
Full Text
View/download PDF

26. TACE-DEB vs. SBRT for hepatocellular carcinoma

Author

Romero, Alejandra Méndez, van der Holt, Bronno, Willemssen, Francois E.J.A., de Man, Rob A., Heijmen, Ben J.M., Habraken, Steven, Westerveld, Henrike, van Delden, Otto M., Klümpen, Heinz-Josef, Tjwa, Eric T.T.L., Braam, Pètra M., Jenniskens, Sjoerd F.M, Vanwolleghem, Thomas, Weytjens, Reinhilde, d'Archambeau, Olivier, de Vos-Geelen, Judith, Buijsen, Jeroen, van der Leij, Christiaan, den Toom, Wilhelm, Sprengers, Dave, Ijzermans, Jan N.M., and Moelker, Adriaan

Subjects
Human medicine
Abstract

Purpose To compare transarterial chemoembolization delivered with drug eluting beads (TACE-DEB) with stereotactioc body radiation therapy (SBRT) in patients with hepatocellular carcinoma (HCC) in a multicenter randomized trial. Materials and Methods Patients were included if they were eligible for TACE. They could also be recruited if they required treatment prior to liver transplantation. A maximum of four TACE-DEB procedures and ablation after incomplete TACE-DEB were both allowed. SBRT was delivered in six fractions of 8-9Gy. Primary end point was time to progression (TTP). Secondary endpoints were local control (LC), overall survival (OS), response rate (RR), toxicity, and quality of life (QoL). The calculated sample size was 100 patients. Results Between May 2015 and April 2020, 30 patients were randomized to the study. Due to slow accrual the trial was closed prematurely. Two patients in the SBRT arm were considered ineligible leaving 16 patients in the TACE-DEB arm and 12 in the SBRT arm. Median follow-up was 28.1 months. Median TTP was 12 months for TACE-DEB and 19 months for SBRT (p=0.15). Median LC was 12 months for TACE-DEB and >40 months (not reached) for SBRT (p=0.075). Median OS was 36.8 months for TACE-DEB and 44.1 months for SBRT (p=0.36). A post-hoc analysis showed 100% for SBRT 1- and 2-year LC, and 54.4% and 43.6% for TACE-DEB (p=0.019). Both treatments resulted in RR>80%. Three episodes of possibly related toxicity grade ≥3 were observed after TACE-DEB. No episodes were observed after SBRT. QoL remained stable after both treatment arms. Conclusions In this trial, TTP after TACE-DEB was not significantly improved by SBRT, while SBRT showed higher local antitumoral activity than TACE-DEB, without detrimental effects on OS, toxicity and QoL. To overcome poor accrual in randomized trials that include SBRT, and to generate evidence for including SBRT in treatment guidelines, international cooperation is needed.

Published
2023

28. Improving survival prediction of oesophageal cancer patients treated with external beam radiotherapy for dysphagia

Author

MS Radiotherapie, Cancer, Jeene, Paul M., Kuijper, Steven C., van den Boorn, Héctor G., El Sharouni, Sherif Y., Braam, Pètra M., Oppedijk, Vera, Verhoeven, Rob H.A., Hulshof, Maarten C.C.M., van Laarhoven, Hanneke W.M., MS Radiotherapie, Cancer, Jeene, Paul M., Kuijper, Steven C., van den Boorn, Héctor G., El Sharouni, Sherif Y., Braam, Pètra M., Oppedijk, Vera, Verhoeven, Rob H.A., Hulshof, Maarten C.C.M., and van Laarhoven, Hanneke W.M.

Published
2022

36. The Dutch–Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases:Clinical Outcomes of 515 Patients and 668 Metastases

Author

Méndez Romero, Alejandra, Schillemans, Wilco, van Os, Rob, Koppe, Friederike, Haasbeek, Cornelis J., Hendriksen, Ellen M., Muller, Karin, Ceha, Heleen M., Braam, Pètra M., Reerink, Onne, Intven, Martijn P.M., Joye, Ines, Jansen, Edwin P.M., Westerveld, Henrike, Koedijk, Merel S., Heijmen, Ben J.M., Buijsen, Jeroen, Méndez Romero, Alejandra, Schillemans, Wilco, van Os, Rob, Koppe, Friederike, Haasbeek, Cornelis J., Hendriksen, Ellen M., Muller, Karin, Ceha, Heleen M., Braam, Pètra M., Reerink, Onne, Intven, Martijn P.M., Joye, Ines, Jansen, Edwin P.M., Westerveld, Henrike, Koedijk, Merel S., Heijmen, Ben J.M., and Buijsen, Jeroen

Abstract

Purpose: Although various studies have reported that stereotactic body radiation therapy (SBRT) for liver metastases has high local control rates and relatively low toxicity, most series included a small number of patients. We aimed to validate these outcomes in a large multi-institution patient cohort treated in accordance with a common protocol. Methods and Materials: A shared web-based registry of patients with liver metastases treated with SBRT was developed by 13 centers (12 in the Netherlands and 1 in Belgium). All the centers had previously agreed on the items to be collected, the fractionation schemes, and the organs-at-risk constraints to be applied. Follow-up was performed at the discretion of the centers. Patient, tumor, and treatment characteristics were entered in the registry. Only liver metastases treated individually as independent targets and with at least 1 radiologic follow-up examination were considered for local control analysis. Toxicity of grade 3 or greater was scored according to the Common Terminology Criteria of Adverse Events (v4.03). Results: Between January 1, 2013, and July 31, 2019, a total of 515 patients were entered in the web-based registry. The median age was 71 years. In total, 668 liver metastases were registered, and 447 were included for local control analysis. The most common primary tumor origin was colorectal cancer (80.3%), followed by lung cancer (8.9%) and breast cancer (4%). The most-used fractionation scheme was 3x18-20 Gy (36.0%), followed by 8x7.5 Gy (31.8%), 5x11-12 Gy (25.5%), and 12x5 Gy (6.7%). The median follow-up time was 1.1 years for local control and 2.3 years for survival. Actuarial 1-year local control was 87%; 1-year overall survival was 84%. Toxicity of grade 3 or greater was found in 3.9% of the patients. Conclusions: This multi-institutional study confirms the high rates of local control and limited toxicity in a large patient cohort. Stereotactic body radiation therapy should be considered a valua

Published
2021

37. Diagnosed with a Rare Cancer:Experiences of Adult Sarcoma Survivors with the Healthcare System-Results from the SURVSARC Study

Author

Drabbe, Cas, Grünhagen, Dirk J, Van Houdt, Winan J, Braam, Pètra M, Soomers, Vicky L M N, Van der Hage, Jos A, De Haan, Jacco J, Keymeulen, Kristien B M I, Husson, Olga, Van der Graaf, Winette T A, Drabbe, Cas, Grünhagen, Dirk J, Van Houdt, Winan J, Braam, Pètra M, Soomers, Vicky L M N, Van der Hage, Jos A, De Haan, Jacco J, Keymeulen, Kristien B M I, Husson, Olga, and Van der Graaf, Winette T A

Abstract

The aim of this study was to explore the experience of rare cancer patients with the healthcare system and examine differences between age groups (adolescents and young adults (AYA, 18-39 years), older adults (OA, 40-69 years) and elderly (≥70 years)). Dutch sarcoma patients, 2-10 years after diagnosis, completed a questionnaire on their experience with the healthcare system, satisfaction with care, information needs, patient and diagnostic intervals (first symptom to first doctor's visit and first doctor's visit to diagnosis, respectively) and received supportive care. In total, 1099 patients completed the questionnaire (response rate 58%): 186 AYAs, 748 OAs and 165 elderly. Many survivors experienced insufficient medical and non-medical guidance (32% and 38%), although satisfaction with care was rated good to excellent by 94%. Both patient and diagnostic intervals were >1 month for over half of the participants and information needs were largely met (97%). AYAs had the longest patient and diagnostic intervals, experienced the greatest lack of (non-)medical guidance, had more desire for patient support groups and used supportive care most often. This nationwide study among sarcoma survivors showed that healthcare experiences differ per age group and identified needs related to the rarity of these tumors, such as improvements concerning (non-)medical guidance and diagnostic intervals.

Published
2021

38. The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases

Author

MS Radiotherapie, Cancer, Méndez Romero, Alejandra, Schillemans, Wilco, van Os, Rob, Koppe, Friederike, Haasbeek, Cornelis J, Hendriksen, Ellen M, Muller, Karin, Ceha, Heleen M, Braam, Pètra M, Reerink, Onne, Intven, Martijn P M, Joye, Ines, Jansen, Edwin P M, Westerveld, Henrike, Koedijk, Merel S, Heijmen, Ben J M, Buijsen, Jeroen, MS Radiotherapie, Cancer, Méndez Romero, Alejandra, Schillemans, Wilco, van Os, Rob, Koppe, Friederike, Haasbeek, Cornelis J, Hendriksen, Ellen M, Muller, Karin, Ceha, Heleen M, Braam, Pètra M, Reerink, Onne, Intven, Martijn P M, Joye, Ines, Jansen, Edwin P M, Westerveld, Henrike, Koedijk, Merel S, Heijmen, Ben J M, and Buijsen, Jeroen

Published
2021

39. Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: a matched comparison of two prospective trials

Author

Arts-assistenten Radiotherapie, Cancer, MS Radiotherapie, van Rossum, Peter S N, Jeene, Paul M, Rozema, Tom, Braam, Pètra M, Lips, Irene M, Muller, Karin, van Kampen, Daphne, Vermeulen, Bram D, Homs, Marjolein Y V, Oppedijk, Vera, Berbée, Maaike, C C M Hulshof, Maarten, Siersema, Peter D, El Sharouni, Sherif Y, Arts-assistenten Radiotherapie, Cancer, MS Radiotherapie, van Rossum, Peter S N, Jeene, Paul M, Rozema, Tom, Braam, Pètra M, Lips, Irene M, Muller, Karin, van Kampen, Daphne, Vermeulen, Bram D, Homs, Marjolein Y V, Oppedijk, Vera, Berbée, Maaike, C C M Hulshof, Maarten, Siersema, Peter D, and El Sharouni, Sherif Y

Published
2021

40. A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancer

Author

MS Radiotherapie, Cancer, de Vos-Geelen, Judith, Hoebers, Frank J.P., Geurts, Sandra M.E., Hoeben, Ann, de Greef, Bianca T.A., Voncken, Francine E.M., Bogers, J. (Hans) A., Braam, Pètra M., Muijs, C. (Kristel) T., de Jong, Martin A., Kasperts, Nicolien, Rozema, Tom, Jeene, Paul M., Blom, Gerrit J., van Dieren, Jolanda M., Hulshof, Maarten C.C.M., van Laarhoven, Hanneke W.M., Grabsch, Heike I., Lemmens, Valery E.P.P., Tjan-Heijnen, Vivianne C.G., Nieuwenhuijzen, Grard A.P., MS Radiotherapie, Cancer, de Vos-Geelen, Judith, Hoebers, Frank J.P., Geurts, Sandra M.E., Hoeben, Ann, de Greef, Bianca T.A., Voncken, Francine E.M., Bogers, J. (Hans) A., Braam, Pètra M., Muijs, C. (Kristel) T., de Jong, Martin A., Kasperts, Nicolien, Rozema, Tom, Jeene, Paul M., Blom, Gerrit J., van Dieren, Jolanda M., Hulshof, Maarten C.C.M., van Laarhoven, Hanneke W.M., Grabsch, Heike I., Lemmens, Valery E.P.P., Tjan-Heijnen, Vivianne C.G., and Nieuwenhuijzen, Grard A.P.

Published
2020

41. Diagnosed with a Rare Cancer: Experiences of Adult Sarcoma Survivors with the Healthcare System—Results from the SURVSARC Study

Author

Drabbe, Cas, primary, Grünhagen, Dirk J., additional, Van Houdt, Winan J., additional, Braam, Pètra M., additional, Soomers, Vicky L. M. N., additional, Van der Hage, Jos A., additional, De Haan, Jacco J., additional, Keymeulen, Kristien B. M. I., additional, Husson, Olga, additional, and Van der Graaf, Winette T. A., additional

Published
2021
Full Text
View/download PDF

43. Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: A matched comparison of two prospective trials

Author

van Rossum, Peter S.N., primary, Jeene, Paul M., additional, Rozema, Tom, additional, Braam, Pètra M., additional, Lips, Irene M., additional, Muller, Karin, additional, van Kampen, Daphne, additional, Vermeulen, Bram D., additional, Homs, Marjolein Y.V., additional, Oppedijk, Vera, additional, Berbée, Maaike, additional, Hulshof, Maarten C.C.M., additional, Siersema, Peter D., additional, and El Sharouni, Sherif Y., additional

Published
2021
Full Text
View/download PDF

44. Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma

Author

Lansu, Jules, primary, Bovée, Judith V. M. G., additional, Braam, Pètra, additional, van Boven, Hester, additional, Flucke, Uta, additional, Bonenkamp, Johannes J., additional, Miah, Aisha B., additional, Zaidi, Shane H., additional, Thway, Khin, additional, Bruland, Øyvind S., additional, Baldini, Elizabeth H., additional, Jebsen, Nina L., additional, Scholten, Astrid N., additional, van den Ende, Piet L. A., additional, Krol, Augustinus D. G., additional, Ubbels, Jan F., additional, van der Hage, Jos A., additional, van Werkhoven, Erik, additional, Klomp, Houke M., additional, van der Graaf, Winette T. A., additional, van Coevorden, Frits, additional, Schrage, Yvonne, additional, van Houdt, Winan J., additional, and Haas, Rick L., additional

Published
2021
Full Text
View/download PDF

46. A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancer

Author

de Vos-Geelen, Judith, primary, Hoebers, Frank J. P., additional, Geurts, Sandra M. E., additional, Hoeben, Ann, additional, de Greef, Bianca T. A., additional, Voncken, Francine E. M., additional, Bogers, J. (Hans) A., additional, Braam, Pètra M., additional, Muijs, C. (Kristel) T., additional, de Jong, Martin A., additional, Kasperts, Nicolien, additional, Rozema, Tom, additional, Jeene, Paul M., additional, Blom, Gerrit J., additional, van Dieren, Jolanda M., additional, Hulshof, Maarten C. C. M., additional, van Laarhoven, Hanneke W. M., additional, Grabsch, Heike I., additional, Lemmens, Valery E. P. P., additional, Tjan-Heijnen, Vivianne C. G., additional, and Nieuwenhuijzen, Grard A. P., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results